Growth Metrics

Plus Therapeutics (PSTV) Short-Term Debt repayments (2025)

Plus Therapeutics (PSTV) has disclosed Short-Term Debt repayments for 1 consecutive years, with $3.3 million as the latest value for Q1 2025.

  • Quarterly Short-Term Debt repayments changed N/A to $3.3 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.3 million for FY2025, N/A changed from the prior year.
  • Short-Term Debt repayments for Q1 2025 was $3.3 million at Plus Therapeutics.
  • The five-year high for Short-Term Debt repayments was $3.3 million in Q1 2025, with the low at $3.3 million in Q1 2025.